Qube Research & Technologies (QRT)’s iPath Series B S&P 500 VIX Short-Term Futures ETN VXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-24,056
Closed -$1.25M 4805
2024
Q1
$1.25M Buy
24,056
+11,590
+93% +$664K ﹤0.01% 2020
2023
Q4
$774K Buy
+12,466
New +$1.01M ﹤0.01% 2061
2022
Q3
Sell
-8,250
Closed -$3.05M 3081
2022
Q2
$3.05M Sell
8,250
-36,075
-81% -$14.2M 0.02% 655
2022
Q1
$18.2M Buy
44,325
+17,355
+64% +$6.39M 0.15% 176
2021
Q4
$8M Sell
26,970
-46,961
-64% -$16.7M 0.06% 407
2021
Q3
$32.9M Buy
73,931
+56,224
+318% +$25.2M 0.41% 37
2021
Q2
$8.35M Sell
17,707
-10,376
-37% -$6.18M 0.1% 255
2021
Q1
$20.5M Buy
28,083
+26,436
+1,605% +$26.4M 0.32% 40
2020
Q4
$1.77M Buy
+1,647
New +$2.14M 0.03% 663

Other funds holding VXX

Qube Research & Technologies (QRT)'s VXX Position: Q2 2024 in Review

Qube Research & Technologies (QRT) sold out of iPath Series B S&P 500 VIX Short-Term Futures ETN (VXX) in Q2 2024, closing a stake of 24,056 shares — an estimated $1.25M sold.

Qube Research & Technologies (QRT) first reported a position in VXX in Q4 2020 and held it in 9 quarters. The position peaked at $32.9M in Q3 2021. 68 funds tracked by Wall St. Rank hold VXX as of Q2 2024.

  • Qube Research & Technologies (QRT) reported no remaining iPath Series B S&P 500 VIX Short-Term Futures ETN position as of Q2 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 24,056 iPath Series B S&P 500 VIX Short-Term Futures ETN shares in Q2 2024, an estimated $1.25M.
  • Qube Research & Technologies (QRT) first reported a position in iPath Series B S&P 500 VIX Short-Term Futures ETN in Q4 2020 and held it in 9 quarters.
  • Qube Research & Technologies (QRT)'s iPath Series B S&P 500 VIX Short-Term Futures ETN position peaked at $32.9M in Q3 2021.
  • 68 funds tracked by Wall St. Rank held iPath Series B S&P 500 VIX Short-Term Futures ETN as of Q2 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2024, filed 14 Aug 2024.